Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.79
Delayed Data
As of Feb 21
 -0.25 / -2.08%
Today’s Change
8.67
Today|||52-Week Range
14.15
+10.19%
Year-to-Date

Today’s Trading

Previous close12.04
Today’s open12.07
Day’s range11.75 - 12.10
Volume501,809
Average volume (3 months)931,881
Market cap$1.3B
Dividend yield8.31%
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+142.77%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+97.09%
P/E ratio33.7
Price/Sales9.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.25-0.96%
EBSEmergent BioSolution...-0.41-1.35%
AXONAxovant Sciences Ltd-0.03-0.25%
DERMDermira Inc-0.23-0.68%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$133.6M
Annual profit (last year)$59.5M
Net profit margin44.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs